FDA Commissioner Nomination On Hold Pending Plan B Decision
Executive Summary
Senate Health Committee Democrats are threatening to delay the confirmation of Lester Crawford as commissioner until the agency makes a decision about Barr's application to switch the emergency contraceptive Plan B to OTC status
You may also be interested in...
FDA’s Crawford Off The Mat: Nomination Revived After Investigation Closes
The conclusion of the HHS Inspector General's investigation into allegations against FDA Commissioner nominee Lester Crawford removes one roadblock in his confirmation process
FDA’s Crawford Off The Mat: Nomination Revived After Investigation Closes
The conclusion of the HHS Inspector General's investigation into allegations against FDA Commissioner nominee Lester Crawford removes one roadblock in his confirmation process
FDA Confirmation Process Hits A Roadblock: Time For Plan B?
Acting FDA Commissioner Lester Crawford's prospects for Senate confirmation appear to be in jeopardy after the Health Committee disclosed concerns about a conduct allegation lodged against the nominee